Barclays’s CARGO Therapeutics CRGX Stock Holding History

Barclays’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,260	Closed	-$261K	–	5526
2025 Q2	$261K	Buy	63,260 +19,067	+43%	+$81.7K	﹤0.01%	4118
2025 Q1	$180K	Sell	44,193 -20,243	-31%	-$136K	﹤0.01%	4108
2024 Q4	$929K	Buy	64,436 +8,082	+14%	+$147K	﹤0.01%	3422
2024 Q3	$1.04M	Buy	56,354 +39,102	+227%	+$699K	﹤0.01%	3333
2024 Q2	$283K	Sell	17,252 -3,306	-16%	-$62.9K	﹤0.01%	3376
2024 Q1	$459K	Buy	+20,558	New	+$489K	﹤0.01%	3647

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's CRGX Position: Q3 2025 in Review

Barclays sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 63,260 shares — an estimated $261K sold.

Barclays first reported a position in CRGX in Q1 2024 and held it in 6 quarters. The position peaked at $1.04M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Barclays reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Barclays sold 63,260 CARGO Therapeutics shares in Q3 2025, an estimated $261K.
Barclays first reported a position in CARGO Therapeutics in Q1 2024 and held it in 6 quarters.
Barclays's CARGO Therapeutics position peaked at $1.04M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.